![Martin Bürmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin Bürmann
Presidente presso REALTECH AG
Profilo
Martin Bürmann is currently the Chairman-Supervisory Board at REALTECH AG, Deputy Chairman-Supervisory Board at MAS Consult AG, Member at BIO Deutschland, and Partner at RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB.
He previously held positions as a Member-Supervisory Board at Heidelberg Pharma AG, Eichbaum-Brauereien AG, Apogenix AG, and ASSIMA Verbundgesellschaft mbH & Co. KG.
Dr. Bürmann received a doctorate degree from the University of Augsburg in 2001 and a graduate degree from Ruprecht-Karls-Universität Heidelberg in 1995.
Posizioni attive di Martin Bürmann
Società | Posizione | Inizio |
---|---|---|
REALTECH AG | Presidente | 01/10/2018 |
MAS Consult AG | Direttore/Membro del Consiglio | - |
BIO Deutschland
![]() BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Corporate Officer/Principal | - |
RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB
![]() RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB Miscellaneous Commercial ServicesCommercial Services RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB is a law firm based in Mannheim, Germany. The German company has a unique perspective on the legal world and operates differently from traditional law firms. The private company's description emphasizes its distinctiveness and alternative approach to legal services. | Corporate Officer/Principal | - |
Precedenti posizioni note di Martin Bürmann
Società | Posizione | Fine |
---|---|---|
ASSIMA Verbundgesellschaft mbH & Co. KG
![]() ASSIMA Verbundgesellschaft mbH & Co. KG Internet RetailRetail Trade ASSIMA Verbundgesellschaft mbH & Co. KG is a German company that specializes in mail order and internet retailing of textiles, clothing, footwear, and leather products. The private company is based in Neuss, Germany. The company was founded in 2002, and the CEO is Siegfried Despineux. | Direttore/Membro del Consiglio | 01/01/2012 |
HEIDELBERG PHARMA AG | Direttore/Membro del Consiglio | 01/01/2011 |
Eichbaum-Brauereien AG /Keilbach/
![]() Eichbaum-Brauereien AG /Keilbach/ Financial ConglomeratesFinance Eichbaum-Brauereien AG /Keilbach/ is led by Jochen Keilbach. The private company is based in Mannheim, Germany. | Direttore/Membro del Consiglio | 01/01/2010 |
Apogenix AG
![]() Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Direttore/Membro del Consiglio | - |
Formazione di Martin Bürmann
Ruprecht-Karls-Universität Heidelberg | Graduate Degree |
University of Augsburg | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
REALTECH AG | Commercial Services |
HEIDELBERG PHARMA AG | Health Technology |
Aziende private | 6 |
---|---|
MAS Consult AG | |
Apogenix AG
![]() Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Health Technology |
Eichbaum-Brauereien AG /Keilbach/
![]() Eichbaum-Brauereien AG /Keilbach/ Financial ConglomeratesFinance Eichbaum-Brauereien AG /Keilbach/ is led by Jochen Keilbach. The private company is based in Mannheim, Germany. | Finance |
ASSIMA Verbundgesellschaft mbH & Co. KG
![]() ASSIMA Verbundgesellschaft mbH & Co. KG Internet RetailRetail Trade ASSIMA Verbundgesellschaft mbH & Co. KG is a German company that specializes in mail order and internet retailing of textiles, clothing, footwear, and leather products. The private company is based in Neuss, Germany. The company was founded in 2002, and the CEO is Siegfried Despineux. | Retail Trade |
BIO Deutschland
![]() BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Commercial Services |
RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB
![]() RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB Miscellaneous Commercial ServicesCommercial Services RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB is a law firm based in Mannheim, Germany. The German company has a unique perspective on the legal world and operates differently from traditional law firms. The private company's description emphasizes its distinctiveness and alternative approach to legal services. | Commercial Services |
- Borsa valori
- Insiders
- Martin Bürmann